429
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Expression of microRNA-155 in circulating T cells is an indicator of immune activation levels in HIV-1 infected patients

, , , , &
Pages 71-77 | Received 01 Jul 2020, Accepted 08 Jul 2021, Published online: 04 Aug 2021

References

  • Nou E, Lo J, Grinspoon SK. Inflammation, immune activation, and cardiovascular disease in HIV. Aids. 2016;30(10):1495–1509.
  • Hazenberg MD, Stuart JWTC, Otto SA, et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy. Blood. 2000;95(1):249–255.
  • Jin C, Zhang F, Wu L, et al. Immune activation and CD127 expression on T lymphocyte subsets of a Chinese cohort of pediatric AIDS patients with different viral responses. Curr HIV Res. 2012;10(7):584–591.
  • Guihot A, Dentone C, Assoumou L, et al. Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia. Aids. 2016;30(2):327–330.
  • Benito JM, Zabay JM, Gil J, et al. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14(2):128–135.
  • Ji S, Jin C, Höxtermann S, et al. Prevalence and Influencing Factors of Thyroid Dysfunction in HIV-Infected Patients. Biomed Res Int. 2016; 2016:1–11.
  • Jin C, Ji S, Xie T, et al. Severe dyslipidemia and immune activation in HIV patients with dysglycemia. HIV Clin Trials. 2016;17(5):189–196.
  • Dentone C, Fenoglio D, Schenone E, et al. Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous system. HIV Clin Trials. 2015;16(5):190–196.
  • Jin C, Peng X, Liu F, et al. MicroRNA-181 expression regulates specific post-transcriptional level of SAMHD1 expression in vitro . Biochem Biophys Res Commun. 2014;452(3):760–767.
  • Rice AP. Roles of microRNAs and long-noncoding RNAs in human immunodeficiency virus replication. Wiley Interdiscip Rev RNA. 2015;6(6):661–670.
  • Jin C, Peng X, Xie T, et al. Detection of the long noncoding RNAs nuclear-enriched autosomal transcript 1 (NEAT1) and metastasis associated lung adenocarcinoma transcript 1 in the peripheral blood of HIV-1-infected patients. HIV Med. 2016;17(1):68–72.
  • Seddiki N, Brezar V, Ruffin N, et al. Role of miR-155 in the regulation of lymphocyte immune function and disease. Immunology 2014;142(1):32–38.
  • Jin C, Cheng L, Lu X, et al. Elevated expression of miRNA-155 is associated with the differentiation of CD8 + T cells in patients with HIV-1. Mol Med Rep. 2017;16(2):1584–1589.
  • Gracias DT, Stelekati E, Hope JL, et al. The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. Nat Immunol. 2013;14(6):593–602.
  • Salaun B, Yamamoto T, Badran B, et al. Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets. J Transl Med. 2011;9:44.
  • Lind EF, Elford AR, Ohashi PS. Micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges. J Immunol. 2013;190(3):1210–1216.
  • Jin C, Peng X, Liu F, et al. Interferon-induced sterile alpha motif and histidine/aspartic acid domain-containing protein 1 expression in astrocytes and microglia is mediated by microRNA-181a. Aids. 2016;30(13):2053–2064.
  • Peng H, Li Q-L, Hou S-H, et al. Association of genetic polymorphisms in CD8+ T cell inhibitory genes and susceptibility to and progression of chronic HBV infection. Infect Genet Evol. 2015; 36:467–474.
  • Ye B, Liu X, Li X, Kong H, Tian L, Chen Y. T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. Cell Death Dis. 2015;6:e1694.
  • Jin CZ, et al. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China. Chin Med J (Engl). 2009;122(5):530–535.
  • Martinez B, Peplow PV. MicroRNAs as biomarkers of diabetic retinopathy and disease progression. Neural Regen Res. 2019;14(11):1858–1869.
  • Melak T, Baynes HW. Circulating microRNAs as possible biomarkers for coronary artery disease: a narrative review. EJIFCC 2019;30(2):179–194.
  • Giri BR, Mahato RI, Cheng G. Roles of microRNAs in T cell immunity: Implications for strategy development against infectious diseases. Med Res Rev. 2019;39(2):706–732.
  • Tao Y, Ai R, Hao Y, et al. Role of miR-155 in immune regulation and its relevance in oral lichen planus. Exp Ther Med. 2019;17(1):575–586.
  • Seddiki N, Swaminathan S, Phetsouphanh C, Kelleher AD. miR-155 is differentially expressed in Treg subsets, which may explain expression level differences of miR-155 in HIV-1 infected patients. Blood 2012;119(26):6396–6397.
  • Cheng YQ, Ren JP, Zhao J, et al. MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection. Immunology 2015;145(4):485–497.
  • Jin C, Cheng L, Höxtermann S, et al. MicroRNA-155 is a biomarker of T-cell activation and immune dysfunction in HIV-1-infected patients. HIV Med. 2017;18(5):354–362.
  • Imaizumi T, Tanaka H, Tajima A, et al. IFN-γ and TNF-α synergistically induce microRNA-155 which regulates TAB2/IP-10 expression in human mesangial cells. Am J Nephrol. 2010;32(5):462–468.
  • Tsai CY, Allie SR, Zhang W, Usherwood EJ. MicroRNA miR-155 affects antiviral effector and effector Memory CD8 T cell differentiation. J Virol. 2013;87(4):2348–2351.
  • Hu J-Y, Zhang J, Ma J-Z, et al. MicroRNA-155-IFN-γ feedback loop in CD4(+)T cells of erosive type oral lichen planus. Sci Rep. 2015;5:16935.
  • Singh UP, Murphy AE, Enos RT, et al. miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses. Immunology 2014;143(3):478–489.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.